Business Relations Table

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

BR-Relations: 130

From Domain	Role	To Domain	Path
arya-4a618f.webflow.io	>>isReferenceFrom	aryacp.com	/career-listing/principal
bit.ly	>>isReferenceFrom	aryacp.com	/the-dose/race-disparities-in-breast-cancer-treatment-and-adverse-effects-among-non-hispanic-women-a-comprehensive-analysis
prn.to	>>isReferenceFrom	aryacp.com	/the-dose/race-disparities-in-breast-cancer-treatment-and-adverse-effects-among-non-hispanic-women-a-comprehensive-analysis
ncbi.nlm.nih.gov	>>isReferenceFrom	aryacp.com	/the-dose/race-disparities-in-breast-cancer-treatment-and-adverse-effects-among-non-hispanic-women-a-comprehensive-analysis
ichnossciences.com	>>isReferenceFrom	aryacp.com	/the-dose/pfizer-demonstrates-committment-to-oncology-with-43-billion-acquisition-of-seagen
ophthalmologytimes.com	>>isReferenceFrom	aryacp.com	/the-dose/astellas-acquires-iveric-bio-for-5-9-b
gene.com	>>isReferenceFrom	aryacp.com	/the-dose/astellas-acquires-iveric-bio-for-5-9-b
investor.lineagecell.com	>>isReferenceFrom	aryacp.com	/the-dose/astellas-acquires-iveric-bio-for-5-9-b
europe.ophthalmologytimes.com	>>isReferenceFrom	aryacp.com	/the-dose/astellas-acquires-iveric-bio-for-5-9-b
investors.biontech.de	>>isReferenceFrom	aryacp.com	/the-dose/new-data-demonstrate-that-carvykti-reduces-risk-of-disease-progression-by-74-in-multiple-myeloma-mm
accesswire.com	>>isReferenceFrom	aryacp.com	/the-dose/new-data-demonstrate-that-carvykti-reduces-risk-of-disease-progression-by-74-in-multiple-myeloma-mm
daiichisankyo.com	>>isReferenceFrom	aryacp.com	/the-dose/new-data-demonstrate-that-carvykti-reduces-risk-of-disease-progression-by-74-in-multiple-myeloma-mm
pfizer.com	>>isReferenceFrom	aryacp.com	/the-dose/new-data-demonstrate-that-carvykti-reduces-risk-of-disease-progression-by-74-in-multiple-myeloma-mm
old-prod.asco.org	>>isReferenceFrom	aryacp.com	/the-dose/new-data-demonstrate-that-carvykti-reduces-risk-of-disease-progression-by-74-in-multiple-myeloma-mm
ir.tgtherapeutics.com	>>isReferenceFrom	aryacp.com	/the-dose/eisai-and-biogens-alzheimer-asset-leqembi-recieves-fda-full-approval
quanterix.com	>>isReferenceFrom	aryacp.com	/the-dose/eisai-and-biogens-alzheimer-asset-leqembi-recieves-fda-full-approval
roche.com	>>isReferenceFrom	aryacp.com	/the-dose/eisai-and-biogens-alzheimer-asset-leqembi-recieves-fda-full-approval
centerforbiosimilars.com	>>isReferenceFrom	aryacp.com	/the-dose/following-legal-battles-with-abbvie-humira-adalimumab-biosimilars-have-launched-in-the-u-s
formycon.com	>>isReferenceFrom	aryacp.com	/the-dose/following-legal-battles-with-abbvie-humira-adalimumab-biosimilars-have-launched-in-the-u-s
samsungbioepis.com	>>isReferenceFrom	aryacp.com	/the-dose/following-legal-battles-with-abbvie-humira-adalimumab-biosimilars-have-launched-in-the-u-s

1 2 3 ... 7 Nächste

Business Relations Table - o4.fyi ()

BR-Editor

Domain-Statistiken für "aryacp.com"

BR-Relations: 130